By Siddhi Mahatole and Puyaan Singh July 7 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved ...

Shares of Vera Therapeutics rose about 8% Tuesday after the Food and Drug Administration approved its treatment for a kidney ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

The clearance marks another step forward in treatment for IgA nephropathy and sets up a commercial battle with Otsuka, which ...

The National Institute for Health and Care Excellence (NICE) has recommended sparsentan (Filspari, Vifor Pharma) for treating primary immunoglobulin A nephropathy in adults. The recommendation ...

Finerenone shows promise in slowing chronic kidney disease progression in non-diabetic patients, according to recent global ...

New drugs, dietary changes can help reduce proteinuria ...

Kidney failure treatment without dialysis can involve conservative management, which means managing symptoms and attempting to preserve kidney function, or a kidney transplant. Kidney failure, also ...

Dopamine is an inotropic agent that has vasodilatory effects at low doses. It is a common belief that low-dose dopamine may be helpful in the prevention and treatment of acute renal failure and is ...